Literature DB >> 24970479

Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer.

Rebecca Burrell1, Nnennaya Kanu2, David Endesfelder3,4, Nicholas McGranahan1, Mike Howell5, Peter J Parker6,7, Julian Downward8, Charles Swanton1,1, Maik Kschischo3.   

Abstract

Chromosomal instability (CIN) is associated with poor outcome in epithelial malignancies, including breast carcinomas. Evidence suggests that prognostic signatures in estrogen receptor-positive (ER(+)) breast cancer define tumors with CIN and high proliferative potential. Intriguingly, CIN induction in lower eukaryotic cells and human cells is context dependent, typically resulting in a proliferation disadvantage but conferring a fitness benefit under strong selection pressures. We hypothesized that CIN permits accelerated genomic evolution through the generation of diverse DNA copy-number events that may be selected during disease development. In support of this hypothesis, we found evidence for selection of gene amplification of core regulators of proliferation in CIN-associated cancer genomes. Stable DNA copy-number amplifications of the core regulators TPX2 and UBE2C were associated with expression of a gene module involved in proliferation. The module genes were enriched within prognostic signature gene sets for ER(+) breast cancer, providing a logical connection between CIN and prognostic signature expression. Our results provide a framework to decipher the impact of intratumor heterogeneity on key cancer phenotypes, and they suggest that CIN provides a permissive landscape for selection of copy-number alterations that drive cancer proliferation. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24970479      PMCID: PMC4167338          DOI: 10.1158/0008-5472.CAN-13-2664

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 2.  Cancer chromosomal instability: therapeutic and diagnostic challenges.

Authors:  Nicholas McGranahan; Rebecca A Burrell; David Endesfelder; Marco R Novelli; Charles Swanton
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

3.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer.

Authors:  Toshiaki Watanabe; Takashi Kobunai; Yoko Yamamoto; Keiji Matsuda; Soichiro Ishihara; Keijiro Nozawa; Hideki Yamada; Tamuro Hayama; Eisuke Inoue; Junko Tamura; Hisae Iinuma; Takashi Akiyoshi; Tetsuichiro Muto
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

6.  The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.

Authors:  Jens K Habermann; Jana Doering; Sampsa Hautaniemi; Uwe J Roblick; Nana K Bündgen; Daniel Nicorici; Ulrike Kronenwett; Shruti Rathnagiriswaran; Rama K R Mettu; Yan Ma; Stefan Krüger; Hans-Peter Bruch; Gert Auer; Nancy L Guo; Thomas Ried
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

7.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Authors:  Christos Sotiriou; Pratyaksha Wirapati; Sherene Loi; Adrian Harris; Steve Fox; Johanna Smeds; Hans Nordgren; Pierre Farmer; Viviane Praz; Benjamin Haibe-Kains; Christine Desmedt; Denis Larsimont; Fatima Cardoso; Hans Peterse; Dimitry Nuyten; Marc Buyse; Marc J Van de Vijver; Jonas Bergh; Martine Piccart; Mauro Delorenzi
Journal:  J Natl Cancer Inst       Date:  2006-02-15       Impact factor: 13.506

8.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Laura Poliseno; Leonardo Salmena; Jiangwen Zhang; Brett Carver; William J Haveman; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

9.  Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells.

Authors:  Bret R Williams; Vineet R Prabhu; Karen E Hunter; Christina M Glazier; Charles A Whittaker; David E Housman; Angelika Amon
Journal:  Science       Date:  2008-10-31       Impact factor: 47.728

10.  Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells.

Authors:  Silvia Stingele; Gabriele Stoehr; Karolina Peplowska; Jürgen Cox; Matthias Mann; Zuzana Storchova
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

View more
  25 in total

1.  Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers.

Authors:  Xuan Liu; Zhongqi Ge; Fei Yang; Alejandro Contreras; Sanghoon Lee; Jason B White; Yiling Lu; Marilyne Labrie; Banu K Arun; Stacy L Moulder; Gordon B Mills; Helen Piwnica-Worms; Jennifer K Litton; Jeffrey T Chang
Journal:  NPJ Breast Cancer       Date:  2022-05-10

2.  Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.

Authors:  Mehmet A Bilen; Brian I Rini; Martin H Voss; James Larkin; John B A G Haanen; Laurence Albiges; Lance C Pagliaro; Eric G Voog; Elaine T Lam; Nikolay Kislov; Bradley A McGregor; Aly-Khan A Lalani; Bo Huang; Alessandra di Pietro; Stan Krulewicz; Paul B Robbins; Toni K Choueiri
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 13.801

3.  Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma.

Authors:  Andres F Correa; Karen J Ruth; Tahseen Al-Saleem; Jianming Pei; Essel Dulaimi; Debra Kister; Michelle Collins; Phillip H Abbosh; Michael J Slifker; Eric Ross; Robert G Uzzo; Joseph R Testa
Journal:  Cancer Biol Ther       Date:  2020-03-01       Impact factor: 4.742

4.  Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer.

Authors:  Chao Liu; Sriganesh Srihari; Samir Lal; Benoît Gautier; Peter T Simpson; Kum Kum Khanna; Mark A Ragan; Kim-Anh Lê Cao
Journal:  Mol Oncol       Date:  2015-09-26       Impact factor: 6.603

Review 5.  Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Med Sci (Basel)       Date:  2020-03-23

6.  Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.

Authors:  Renzo G DiNatale; Alexander N Gorelick; Vladimir Makarov; Kyle A Blum; Andrew W Silagy; Benjamin Freeman; Diego Chowell; Julian Marcon; Roy Mano; Alex Sanchez; Kyrollis Attalla; Stanley Weng; Martin Voss; Robert J Motzer; Paul Russo; Jonathan A Coleman; Victor E Reuter; Ying-Bei Chen; Timothy A Chan; Ed Reznik; Satish K Tickoo; A Ari Hakimi
Journal:  Eur Urol Focus       Date:  2019-12-06

Review 7.  Cytokinesis Failure Leading to Chromosome Instability in v-Src-Induced Oncogenesis.

Authors:  Yuji Nakayama; Shuhei Soeda; Masayoshi Ikeuchi; Keiko Kakae; Naoto Yamaguchi
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

8.  Pan-cancer analysis distinguishes transcriptional changes of aneuploidy from proliferation.

Authors:  Christopher Buccitelli; Lorena Salgueiro; Konstantina Rowald; Rocio Sotillo; Balca R Mardin; Jan O Korbel
Journal:  Genome Res       Date:  2017-03-20       Impact factor: 9.043

9.  Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth.

Authors:  Konstantina Rowald; Martina Mantovan; Joana Passos; Christopher Buccitelli; Balca R Mardin; Jan O Korbel; Martin Jechlinger; Rocio Sotillo
Journal:  Cell Rep       Date:  2016-06-09       Impact factor: 9.423

10.  Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.

Authors:  Liang Guo; Zhiming Ding; Nunu Huang; Zhengsong Huang; Nu Zhang; Zhibo Xia
Journal:  Cell Cycle       Date:  2017-08-02       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.